| Patient | Ida B. Wells |
|---|---|
| Date of birth | 1862-07-16 |
| Identifiers | MRN HR-ET022-SYN-TD; SSN (made up) 000-22-5903 |
| Document date | 1931-01-05 |
| Author | Cordelia Ashworth-Banks, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New chronic kidney disease, probably G3b A2, of uncertain cause in a 68-year-old Black woman with tiredness, ankle swelling and high blood pressure readings: race-free eGFR 40 by creatinine and 38 with cystatin C, and a urine albumin-to-creatinine ratio of 240 mg/g. Please advise on the cause and further evaluation, APOL1 genetic testing, kidney-protective treatment and its order, the anemia and mineral findings, and how and when to plan for the future. [S]
Urgency: Within two weeks, on the day of her two-week visit, after the repeat urine test and the kidney ultrasound. [S]
Questions for the consultant:
Mrs. Wells is a journalist and civic leader, active and independent, who has been tired for some months and notices ankle swelling by evening. She has taken over-the-counter naproxen for knee aching for about a year; it was stopped today. She has no diabetes symptoms, no known kidney disease, and no blood in the urine. She recalls being told by another clinic two years ago that a kidney test was normal and is obtaining that report. Her parents and an infant brother died in an epidemic in her youth; no family kidney history is known. Blood pressure 164/94 (average of two readings), pulse 78, weight 70.4 kg, BMI 28.6; trace ankle swelling. Results today: sodium 139, potassium 4.6, bicarbonate 22 mmol/L; urea nitrogen 28, creatinine 1.42 mg/dL; eGFR 40 (CKD-EPI 1926 creatinine, race-free); cystatin C 1.68 mg/L, eGFR 38 (creatinine and cystatin C); urine albumin-to-creatinine ratio 240 mg/g; fasting glucose 94 mg/dL and A1c 5.6%; hemoglobin 11.2 g/dL, ferritin 168 ng/mL, transferrin saturation 24%; calcium 9.2, phosphate 3.8 mg/dL; intact PTH 84 pg/mL; 25-hydroxyvitamin D 17 ng/mL; LDL 136 mg/dL; TSH 1.9; PHQ-9 4. ECG: sinus rhythm with voltage criteria for left ventricular hypertrophy. Sent today: urinalysis with microscopy, serum protein electrophoresis with free light chains, hepatitis B, hepatitis C and HIV tests. Planned: a home blood pressure monitor for seven days, a repeat urine albumin test and a kidney ultrasound on the morning of your visit. She asks to see every result and how each was calculated [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee aching (no more than 3,000 mg a day), in place of naproxen | One or two tablets up to three times a day as needed | Oral route | 1931-01-05 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tiredness for some months and ankle swelling by evening, with a raised creatinine (1.42 mg/dL, race-free eGFR 40, confirmed at 38 with cystatin C) and albumin in the urine (240 mg/g) found today; cause and chronicity to be established | active | confirmed | R94.4 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks. |
| Elevated blood pressure at intake (164/94 mmHg, average of two readings), without a diagnosis of hypertension; home readings for one week to confirm | active | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died in the yellow fever epidemic when she was 16 | D (CLM-0002) | |
| mother | Died in the yellow fever epidemic when she was 16 | D (CLM-0002) | |
| brother | An infant brother died in the same yellow fever epidemic | D (CLM-0002) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1931-01-05 | Body height | 157 | cm | S |
| 1931-01-05 | Body weight | 70.4 | kg | S |
| 1931-01-05 | Body mass index (BMI) [Ratio] | 28.6 | kg/m2 | S |
| 1931-01-05 | Systolic blood pressure | 164 | mm[Hg] | S |
| 1931-01-05 | Diastolic blood pressure | 94 | mm[Hg] | S |
| 1931-01-05 | Heart rate | 78 | /min | S |
| 1931-01-05 | Respiratory rate | 16 | /min | S |
| 1931-01-05 | Body temperature | 36.6 | Cel | S |
| 1931-01-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1931-01-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1931-01-05 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1931-01-05 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 22 | mmol/L | Keep at 22 or above in kidney disease | Normal | S |
| 1931-01-05 | Urea nitrogen [Mass/volume] in Serum or Plasma | 28 | mg/dL | 8-23 mg/dL | High | S |
| 1931-01-05 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1931-01-05 | Creatinine [Mass/volume] in Serum or Plasma | 1.42 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 1931-01-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1926)/1.73 sq M | 40 | mL/min/{1.73_m2} | 60 or higher without other kidney damage markers; 45 to 59 is G3a, 30 to 44 is G3b, 15 to 29 is G4 | Low | S |
| 1931-01-05 | Cystatin C [Mass/volume] in Serum or Plasma | 1.68 | mg/L | 0.53-0.95 mg/L | High | S |
| 1931-01-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 1926)/1.73 sq M | 38 | mL/min/{1.73_m2} | The confirmatory estimate KDIGO prefers when decisions depend on accuracy; 30 to 44 is G3b | Low | S |
| 1931-01-05 | Albumin/Creatinine [Mass Ratio] in Urine | 240 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3) | High | S |
| 1931-01-05 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | Below 5.7% is normal; 6.5% or higher is diabetes | Normal | S |
| 1931-01-05 | Hemoglobin [Mass/volume] in Blood | 11.2 | g/dL | Anemia in women is below 12.0 g/dL | Low | S |
| 1931-01-05 | Ferritin [Mass/volume] in Serum or Plasma | 168 | ng/mL | 30-300 ng/mL | Normal | S |
| 1931-01-05 | Iron saturation [Mass Fraction] in Serum or Plasma | 24 | % | 20-50% | Normal | S |
| 1931-01-05 | Calcium [Mass/volume] in Serum or Plasma | 9.2 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1931-01-05 | Phosphate [Mass/volume] in Serum or Plasma | 3.8 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1931-01-05 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 84 | pg/mL | 15-65 pg/mL | High | S |
| 1931-01-05 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 17 | ng/mL | Below 20 ng/mL deficient; 20 to 29 insufficient | Low | S |
| 1931-01-05 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 1931-01-05 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 136 | mg/dL | <=99 mg/dL | High | S |
| 1931-01-05 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=50 mg/dL | Normal | S |
| 1931-01-05 | Triglyceride [Mass/volume] in Serum or Plasma | 128 | mg/dL | <=149 mg/dL | Normal | S |
| 1931-01-05 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1931-01-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S |